Authors:
Ben-Ari, Z
Mor, E
Manhaim, V
Barak, O
Bar-Nathan, N
Shaharabani, E
Shapira, Z
Tur-Kaspa, R
Citation: Z. Ben-ari et al., Passive immunization with OMRI-Hep-B for prevention of hepatitis B virus reinfection after liver transplantation, TRANSPLAN P, 33(6), 2001, pp. 2895-2896
Authors:
Mor, E
Cohen, J
Erez, E
Grozovsky, A
Shaharabani, E
Bar-Nathan, N
Yussim, A
Micowiz, R
Shapira, Z
Zinger, P
Citation: E. Mor et al., Short intensive care unit stay reduces septic complications and improves outcome after liver transplantation, TRANSPLAN P, 33(6), 2001, pp. 2939-2940
Authors:
Mor, E
Shaharabani, E
Ben-Ari, Z
Bar-Nathan, N
Yussim, A
Shapira, R
Tur-Kaspa, R
Shapira, Z
Citation: E. Mor et al., Experience with 100 liver transplant recipients at the Rabin Medical Center and Schneider Children's Medical Center, TRANSPLAN P, 33(6), 2001, pp. 2943-2944
Authors:
Klein, T
Shapira, Z
Nathan, NB
Shaharabani, E
Or, H
Zakai, C
Shabtai, E
Yussim, A
Citation: T. Klein et al., Lack of correlation between HLA match and long-term survival in living donor kidney transplantation, TRANSPLAN P, 32(4), 2000, pp. 692-693
Authors:
Mor, E
Bar-Nathan, N
Shapira, R
Simchi, E
Shaharabani, E
Yusim, A
Zehavi, I
Sheinfeld, T
Ben-Ari, Y
Dinari, G
Shapira, Z
Citation: E. Mor et al., Liver transplantation in children: Experience at Schneider's Children's Medical Center, Israel, TRANSPLAN P, 32(4), 2000, pp. 704-705
Authors:
Ben-Ari, Z
Mor, E
Shaharabani, E
Bar-Nathan, N
Shapira, Z
Tur-Kaspa, R
Citation: Z. Ben-ari et al., Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy, TRANSPLAN P, 32(4), 2000, pp. 709-710
Authors:
Ben-Ari, Z
Mor, E
Shaharabani, E
Bar-Nathan, N
Shapira, Z
Tur-Kaspa, R
Citation: Z. Ben-ari et al., Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation, TRANSPLAN P, 32(4), 2000, pp. 714-716